Yazar Araması Sonucu :: Library Catalog

1

Table S6 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer Yazar: Nina Müller (16721126)

Baskı/Yayın Bilgisi 2025
Diğer Yazarlar:

Favorilerime ekle

Kaydedildi:
2

Table S8 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer Yazar: Nina Müller (16721126)

Baskı/Yayın Bilgisi 2025
Diğer Yazarlar:

Favorilerime ekle

Kaydedildi:
3

Table S7 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer Yazar: Nina Müller (16721126)

Baskı/Yayın Bilgisi 2025
Diğer Yazarlar:

Favorilerime ekle

Kaydedildi:
4

Table S5 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer Yazar: Nina Müller (16721126)

Baskı/Yayın Bilgisi 2025
Diğer Yazarlar:

Favorilerime ekle

Kaydedildi:
5

Table S2 from Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Baskı/Yayın Bilgisi 2025
Diğer Yazarlar:

Favorilerime ekle

Kaydedildi:
6

Table S4 from Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Baskı/Yayın Bilgisi 2025
Diğer Yazarlar:

Favorilerime ekle

Kaydedildi:
7

Table S5 from Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Baskı/Yayın Bilgisi 2025
Diğer Yazarlar:

Favorilerime ekle

Kaydedildi:
8

Table S1 from Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Baskı/Yayın Bilgisi 2025
Diğer Yazarlar:

Favorilerime ekle

Kaydedildi:
9

Table S6 from Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Baskı/Yayın Bilgisi 2025
Diğer Yazarlar:

Favorilerime ekle

Kaydedildi:
10

Table S3 from Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Baskı/Yayın Bilgisi 2025
Diğer Yazarlar:

Favorilerime ekle

Kaydedildi:

Table S6 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer Yazar: Nina Müller (16721126)

Table S8 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer Yazar: Nina Müller (16721126)

Table S7 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer Yazar: Nina Müller (16721126)

Table S5 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer Yazar: Nina Müller (16721126)

Table S2 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Table S4 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Table S5 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Table S1 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Table S6 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Table S3 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Table S6 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer Yazar: Nina Müller (16721126)

Table S8 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer Yazar: Nina Müller (16721126)

Table S7 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer Yazar: Nina Müller (16721126)

Table S5 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer Yazar: Nina Müller (16721126)

Table S2 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Table S4 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Table S5 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Table S1 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Table S6 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Table S3 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Yazar: Ruth Flümann (15123900)

Arama Araçları: